DEPARTMENT OF LABORATORY SCIENCES

Patient Name Mrs. NIRMOHAN KAUR Lab No 3221424

UHID/IP No 200011351 / 239177 Sample Date 16/02/2023 5:22PM
Age/Gender 76 Yrs/Female Receiving Date 20/02/2023 2:05PM
Bed No/Ward OPD Report Date 20/02/2023 4:41PM
Referred By Dr. WALK IN Report Status Final

CLINICAL BIOCHEMISTRY/ IMMUNO ASSSAY

Test Name Result Unit Biological Method
Ref. Range
RENAL PROFILE 1
Sample: Serum
UREA.. 184 H mg/dl 15 - 36 Urease with indicator dye

Creatinine 4.80 H mg/dl 0.70 - 1.20 Enzymatic ( creatinine

amidohydrolase)
Uric Acid 7.0 H mg/dl 2.5 - 6.2 Uricase/ peroxidase ( colorimetric)

Calcium *6.8 mg/dl 8.4 - 10.2 Arsenazo dye

Phosphorus 4.8 H mg/dl 2.5 - 4.5 Phosphomolybdate Reduction

Sodium 137 mEq/L 137 - 145 Direct Ion selective electrode

Potassium 3.8 mEq/L 3.5 - 5.1 Direct Ion selective electrode

Albumin 2.90 L gm/dl 3.50 - 5.00 Bromocresol Green (BCG)

*Serum calcium corrected result for low albumin level = 7.68 mg/dl.

--End Of Report--

Dr. SUNITA
DESHMUKH
MBBS MD(Path) Reg No-
MCI-56652
HOD

Printed on 20/02/2023 16:53 Page: 1 Of 3

 DEPARTMENT OF LABORATORY SCIENCES
Patient Name Mrs. NIRMOHAN KAUR Lab No 3221424
UHID/IP No 200011351 / 239177 Sample Date 16/02/2023 5:22PM
Age/Gender 76 Yrs/Female Receiving Date 20/02/2023 2:05PM
Bed No/Ward OPD Report Date 20/02/2023 3:50PM
Referred By Dr. WALK IN Report Status Final

HAEMATOLOGY
Test Name Result Unit Biological Method
Ref. Range
COMPLETE BLOOD COUNT -CBC(HB\TLC\PCV\RBC\PLATELET)
Sample: W. B. EDTA
Haemoglobin Estimation (Hb) 8.5 L gm/dl 12.0 - 15.0 SLS- Hb Method

Total Leukocyte Count (TLC) 12.32 H 10^3/uL 4.00 - 10.00 Flow Cytometry

DLC
Neutrophils 81.4 H % 40.0 - 80.0 Flow Cytometry,Light Microscopy

Absolute Neutrophil Count (ANC) 10.03 H 10^3/µL 2.00 - 7.00 Calculated

Lymphocytes 11.3 L % 20.0 - 40.0 Flow Cytometry,Light Microscopy

Absolute Lymphocyte Count 1.39 10^3/µL 1.00 - 3.00 Calculated

Eosinophils 1.2 % 1.0 - 6.0 Flow Cytometry,Light Microscopy

Absolute Eosinophil Count (AEC) 0.15 10^3/µL 0.02 - 0.50 Calculated

Monocytes 6.0 % 2.0 - 10.0 Flow Cytometry,Light Microscopy

Absolute Monocyte Count 0.74 10^3/µL 0.20 - 1.00 Calculated

Basophils 0.1 % 0.0 - 0.5 Flow Cytometry,Light Microscopy

Absolute Basophil Count 0.01 L 10^3/µL 0.02 - 0.10 Calculated

PCV (Haematocrit) 28.1 L % 36.0 - 46.0 RBC Pulse Height Detection

RBC Count (Red Blood Cell) 3.30 L 10^6/uL 3.80 - 4.80 DC Detection

MCV 85.2 fl 77.0 - 95.0 Calculated

MCH 25.8 pg 25.0 - 33.0 Calculated

MCHC 30.2 L gm/dl 31.0 - 37.0 Calculated

RDW - CV 14.2 H % 11.6 - 14.1 Calculated

Platelet Count 204 10^3/uL 150 - 400 DC Detection

--End Of Report--

Dr. NUTAN SOOD

MBBS MD (Path)
HMC No. 012481
Senior Consultant
Pathologist

Printed on 20/02/2023 16:53 Page: 2 Of 3

 DEPARTMENT OF LABORATORY SCIENCES
Patient Name Mrs. NIRMOHAN KAUR Lab No 3221424
UHID/IP No 200011351 / 239177 Sample Date 16/02/2023 5:22PM
Age/Gender 76 Yrs/Female Receiving Date 20/02/2023 2:05PM
Bed No/Ward OPD Report Date 20/02/2023 3:50PM
Referred By Dr. WALK IN Report Status Final

HAEMATOLOGY
Test Name Result Unit Biological Method
Ref. Range
PROTHROMBIN TIME (WITH INR)
Sample: Sodium citrate plasma
TEST 24.10 H sec 9.50 - 14.62 Clot Detection

MNPT 12.1
INR 1.96 H 0.80 - 1.20 Calculated

Note :
      1. INR is the parameter of choice in monitoring adequacy of oral anticoagulant  
         therapy.Appropriate therapeutic range varies with the disease and
         treatment intensity.
      2. Prolonged INR suggests potential bleeding disorder / bleeding complications
      3. Results should be clinically correlated.

Recommended Therapeutic range for Oral Anticoagulant therapy

INR 2.0 - 3.0:    

      -  Treatment of Venous thrombosis & Pulmonary embolism
      -  Prophylaxis of Venous thrombosis (High resk surgery)
      -  Prevention of systemic embolisum in tissue heart valves, AMI Valvular heart  
         disease & Atrial fibrillation
      -  Bileaflet mechanical valve in aortic position

INR 2.5 - 3.5 : 

      -  Mechanical prosthetic valves
      -  Systemic recurrent emboli

Comments:
Prothrombin time measures the extrinsic coagulation pathway which consists of
activated Factor VII (VIIa), Tissue factor and Proteins of the common pathway
(Factors X, V, II & Fibrinogen). This assay is used to control long term oral
aniticoagulant therapy, evaluation of liver function & to evaluate coagulation
disorders specially factors involved in the extrinsic pathway like Factors V, VII, X,
Prothrombin & Fibrinogen.

--End Of Report--

Dr. SUNITA
DESHMUKH
MBBS MD(Path) Reg No-
MCI-56652
HOD

Printed on 20/02/2023 16:53 Page: 3 Of 3